Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Rheumatology (Oxford, England)（2022）
摘要
ATA-lcSSc patients have a high risk of ILD, albeit with a lower risk of progression compared with ATA-dcSSc, supporting careful screening for ILD in this subgroup.
更多查看译文
关键词
SSc,anti-topoisomerase I,cutaneous form,disease subset,interstitial lung disease,outcome,scleroderma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要